|
These webcasts combines presenter's video and audio with slides. Click on the presenter's name to view in all browsers, including Internet Explorer, Firefox and iPad/iMac.
Click on "PDF" for download slides only as pdf. |
EAHP
Congress 2015 |
 |
Produced
by 
|
|
The European Association of Hospital Pharmacists (EAHP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education | |||||||||
| Keynote Presentations |
|
|||||||||
| Student programme | Patient safety and healthcare improvements - the hospital pharmacist's contribution |
|||||||||
| Highlights | Highlights of German Hospital Pharmacy | M. Baehr C. Langebrake |
||||||||
| Seminar M1 |
Inspired by STOPP/START: a new prescription screening tool for adult patients |
PDF |
||||||||
| Seminar M2 | Risk analysis of the drug development process - focus on the patient | PDF |
||||||||
| Seminar M3 | The use of simulation in pharmacy education | PDF |
||||||||
| Seminar M4 | Design for safety in drug development | PDF |
||||||||
| Seminar M5 | Patient safety and drug supply technologies | PDF |
||||||||
| Seminar M6 | Patient safety and compounding technologies | PDF |
||||||||
| Seminar C1 | Improving patient safety through multidisciplinary teamwork | |||||||||
| Seminar C2 | Budgetary constraints and patient care | PDF |
||||||||
| Seminar C3 | Methodologies underlying patient safety | |||||||||
| Seminar C4 | Error causation and taxonomy | Karin Taxis |
||||||||
| Seminar CL1 | Medication safety in transitions of care | PDF |
||||||||
| Seminar CL2 | Medical device vigilance | PDF |
||||||||
| Seminar CL3 | Patient safety through individualised therapy | Jerzy Palka Anna Wesolowska |
PDF |
|||||||
| Seminar CL4 | Adherence and patient involvement | Patricia van den Bemt |
PDF |
|||||||
| Seminar CL5 | Medication safety in vulnerable patient groups | PDF |
||||||||
| Workshop 1 | Ethical and legal dilemmas: focus on the patient | ||
| Workshop 2 | How to manage methodologies underlying patient and professional safety? |
V. Leroux | |
| Workshop 3 | Patient engagement and communication skills | ||
| Workshop 4 | A systematic approach to pharmaceutical care with a focus on data gathering | ||
| Workshop 5 | The art of writing an abstract | T. Hoppe-Tichy L. J. Kjeldsen |
|
| Workshop 6 | Developing a Lean Management culture | N. Curatolo H. Kjer |
|
| Workshop 7 | Medication reconciliation on admission | Jane Smith Natasha Mogford |
|
| Workshop 8 | Evidence based clinical pharmacy |
|
Satellite
symposia (not ACPE accredited): The information related
to satellite symposia is provided to you by commercial companies, external
to EAHP. EAHP makes no representations or warranties of any kind, express
or implied, about the completeness, accuracy, reliability, suitability
or availability with respect to these presentations or the information,
products, services, or related graphics contained in the presentations
for any purpose. Any reliance you place on such information is therefore
strictly at your own risk. In no event will EAHP be liable for any loss
or damage including without limitation, indirect or consequential loss
or damage, or any loss or damage whatsoever arising from loss of data
or profits arising out of, or in connection with, the presentations.
|
|||
| Bayer | Confidence in Practice with Rivaroxaban in daily use | The importance of adherence and persistence Craig Coleman (USA) Challenges in managing patients treated with NOAC's and multiple comedications Kurt Hersberger (Switzerland) Strategies for prevention and management of bleeding Peter Verhamme (Belgium) |
PDF |
| Accord Healthcare | Medicines Matters - Debating the Challenges of Modern Medicine | Panel discussion with Mark Porter as moderator, Part 1 |
|
| Cubist | Benefits of antibiotic stewardship in the management of acute infections | Chairman's introduction and welcome, Jonathan Cooke UK |
PDF |
| Pfizer | Biosimilars in inflammatory disease: A value perspective |
Introduction Michael Sobanja (NHS,UK) Biosimilars: how they are regulated Rieke Alten, Germany Understanding the role of long-term data in cost predictability Joao Fonseca The role of Pfizer in evolving environment Sylvie St-Laurent |
|
| Pfizer | Optimising biologic care in an evolving landscape: Real world decisions in rheumatology |
Budgetary challenges in rheumatology Michael Sobanja (NHS, UK) Are you getting what you budget for? Rob Moots (UK) Real world cost of biologic therapy: a European perspective Luca Degli Esposti (It) |
|
| Synergy satellite breakfast event (ACPE accredited) | Barcoding the single dose of drugs to improve patient safety | Bedside scanning, the final frontier Thomas de Rijdt |
PDF |
| Synergy (ACPE accredited) |
Targeted drugs - Scattered goals | Targeting the immune system, Dirk Jaeger Personalized pediatric oncology, Olaf Witt Handling targeted therapie in oncology - Main challenges for pharmacists Tillman Schoening |
PDF |
| Synergy (ACPE accredited) | Evidence and pharmacovigilance of monoclonal antibody reference and biosimilar products | How to evaluate a biosimilar from a hospital pharmacists perpective Irene Krämer Issues around production, dosage forms, naming, pharmacovigilance of mab and biosimilars Jos Kosterink Monoclonal antibody biosimilars: robustness of product vs clinical experience Hakan Mellstedt |
PDF |